Skip to main content
Veterinary Medicines

LINCO – SPECTIN, Injekční roztok

Authorised
  • Lincomycin
  • Spectinomycin

Product identification

Medicine name:
LINCO – SPECTIN, Injekční roztok
Active substance:
  • Lincomycin
  • Spectinomycin
Target species:
  • Cat
  • Pig
  • Dog
  • Sheep
  • Cattle (pre-ruminant)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Lincomycin
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Spectinomycin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cat
    • Pig
      • Meat and offal
        14
        day
    • Dog
    • Sheep
      • Meat and offal
        15
        day
      • Milk
        no withdrawal period
    • Cattle (pre-ruminant)
      • Meat and offal
        21
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Authorisation status:
  • Valid
Authorised in:
  • Czechia
Available in:
  • Czechia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Ceska Republika s.r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium SA
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 99/148/87-C
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 26/10/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."